EMA Authorised: Pritor (telmisartan) — Bayer AG

View source ↗

Summary

The EMA authorised the marketing of Pritor (telmisartan) by Bayer AG for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Pritor (telmisartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Bayer AG. Decision date: 03/04/2025